Skip to main content
SpringerLink
Log in
Book cover

The Kidney pp 19–35Cite as

Polycystic Kidney Disease

  • Chapter

  • 2754 Accesses

Abstract

Autosomal dominant (ADPKD) and autosomal recessive (ARPKD) polycystic kidney diseases represent clinically challenging disease states that affect adults and children, respectively. The newly discovered molecular and genetic mechanisms of disease have provided great insight into each disorder. ADPKD is usually characterized by an adult patient with many large, bilateral, renal cysts that distort and destroy renal parenchyma over time and lead to renal insufficiency. Hypertension is an important and modifiable symptom of the disease. If left unmanaged, hypertension and renal insufficiency would quickly lead to morbidity and mortality in most ADPKD patients. These patients also have a variety of surgical and medical complications, such as infections, cyst hemorrhage, nephrolithiasis, renal neoplasms, and aneurysms. ARPKD is a rare but usually fatal hepatorenal disorder affecting infants and young children. It is closely associated with hepatic fibrosis, and patients with this disease can rapidly develop renal and hepatic failure that necessitates heroic medical and surgical measures. Though diagnosis of these diseases has historically been radiographic, new molecular/genetic techniques can allow for a very specific characterization of mutations, which may have clinical ramifications. Ongoing research has been fruitful, though effective treatments for these diseases, aside from palliative management, have been difficult to develop. Nonetheless, these disease states are important for any kidney-focused clinician to understand well.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935–1980. Am J Kidney Dis. 1983;2(6):630–9.

    Article  CAS  PubMed  Google Scholar 

  2. Grantham JJ. The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances. Am J Kidney Dis. 1996;28(6):788–803.

    Article  CAS  PubMed  Google Scholar 

  3. Hildebrandt F. Genetic renal diseases in children. Curr Opin Pediatr. 1995;7(2):182–91.

    Article  CAS  PubMed  Google Scholar 

  4. Wilson PD. Polycystic kidney disease: new understanding in the pathogenesis. Int J Biochem Cell Biol. 2004;36(10):1868–73.

    Article  CAS  PubMed  Google Scholar 

  5. Gabow PA. Polycystic kidney disease: clues to pathogenesis. Kidney Int. 1991;40(6):989–96.

    Article  CAS  PubMed  Google Scholar 

  6. Paul BM, Consugar MB, Ryan Lee M, Sundsbak JL, Heyer CM, Rossetti S, Kubly VJ, Hopp K, Torres VE, Coto E, et al. Evidence of a third ADPKD locus is not supported by re-analysis of designated PKD3 families. Kidney Int. 2013;85:383–92.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Seeger-Nukpezah T, Proia DA, Egleston BL, Nikonova AS, Kent T, Cai KQ, Hensley HH, Ying W, Chimmanamada D, Serebriiskii IG, et al. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease. Proc Natl Acad Sci U S A. 2013;110(31):12786–91.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Proesmans W, Van Damme B, Casaer P, Marchal G. Autosomal dominant polycystic kidney disease in the neonatal period: association with a cerebral arteriovenous malformation. Pediatrics. 1982;70(6):971–5.

    CAS  PubMed  Google Scholar 

  9. Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (2011) Campbell-Walsh urology tenth edition, 10th revised ed. Elsevier, Philadelphia.

    Google Scholar 

  10. Breuning MH, Reeders ST, Brunner H, Ijdo JW, Saris JJ, Verwest A, van Ommen GJ, Pearson PL. Improved early diagnosis of adult polycystic kidney disease with flanking DNA markers. Lancet. 1987;2(8572):1359–61.

    Article  CAS  PubMed  Google Scholar 

  11. Reeders ST, Breuning MH, Davies KE, Nicholls RD, Jarman AP, Higgs DR, Pearson PL, Weatherall DJ. A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature. 1985;317(6037):542–4.

    Article  CAS  PubMed  Google Scholar 

  12. Ryynanen M, Dolata MM, Lampainen E, Reeders ST. Localisation of a mutation producing autosomal dominant polycystic kidney disease without renal failure. J Med Genet. 1987;24(8):462–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Qian F, Watnick TJ, Onuchic LF, Germino GG. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell. 1996;87(6):979–87.

    Article  CAS  PubMed  Google Scholar 

  14. Hateboer N, van Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, Breuning M, Ravine D. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet. 1999;353(9147):103–7.

    Article  CAS  PubMed  Google Scholar 

  15. Braun WE. Autosomal dominant polycystic kidney disease: emerging concepts of pathogenesis and new treatments. Cleve Clin J Med. 2009;76(2):97–104.

    Article  PubMed  Google Scholar 

  16. Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, Elia AE, Lu W, Brown EM, Quinn SJ, et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet. 2003;33(2):129–37.

    Article  CAS  PubMed  Google Scholar 

  17. Oatley P, Talukder MM, Stewart AP, Sandford R, Edwardson JM. Polycystin-2 induces a conformational change in polycystin-1. Biochemistry. 2013;52:5280–7.

    Article  CAS  PubMed  Google Scholar 

  18. Pazour GJ. Intraflagellar transport and cilia-dependent renal disease: the ciliary hypothesis of polycystic kidney disease. J Am Soc Nephrol. 2004;15(10):2528–36.

    Article  PubMed  Google Scholar 

  19. Steinman TI. Polycystic kidney disease: a 2011 update. Curr Opin Nephrol Hypertens. 2012;21(2):189–94.

    Article  CAS  PubMed  Google Scholar 

  20. Knudson Jr AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68(4):820–3.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Bisceglia M, Galliani CA, Senger C, Stallone C, Sessa A. Renal cystic diseases: a review. Adv Anat Pathol. 2006;13(1):26–56.

    Article  PubMed  Google Scholar 

  22. Jilg CA, Drendel V, Bacher J, Pisarski P, Neeff H, Drognitz O, Schwardt M, Glasker S, Malinoc A, Erlic Z, et al. Autosomal dominant polycystic kidney disease: prevalence of renal neoplasias in surgical kidney specimens. Nephron Clin Pract. 2013;123(1–2):13–21.

    Article  PubMed  Google Scholar 

  23. Lennerz JK, Spence DC, Iskandar SS, Dehner LP, Liapis H. Glomerulocystic kidney: one hundred-year perspective. Arch Pathol Lab Med. 2010;134(4):583–605.

    CAS  PubMed  Google Scholar 

  24. Rossetti S, Harris PC. Genotype-phenotype correlations in autosomal dominant and autosomal recessive polycystic kidney disease. J Am Soc Nephrol. 2007;18(5):1374–80.

    Article  CAS  PubMed  Google Scholar 

  25. Delaney VB, Adler S, Bruns FJ, Licinia M, Segel DP, Fraley DS. Autosomal dominant polycystic kidney disease: presentation, complications, and prognosis. Am J Kidney Dis. 1985;5(2):104–11.

    Article  CAS  PubMed  Google Scholar 

  26. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med. 1993;329(5):332–42.

    Article  CAS  PubMed  Google Scholar 

  27. Milutinovic J, Fialkow PJ, Agodoa LY, Phillips LA, Rudd TG, Bryant JI. Autosomal dominant polycystic kidney disease: symptoms and clinical findings. Q J Med. 1984;53(212):511–22.

    CAS  PubMed  Google Scholar 

  28. Zeier M, Geberth S, Ritz E, Jaeger T, Waldherr R. Adult dominant polycystic kidney disease – clinical problems. Nephron. 1988;49(3):177–83.

    Article  CAS  PubMed  Google Scholar 

  29. Gabow PA, Duley I, Johnson AM. Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1992;20(2):140–3.

    Article  CAS  PubMed  Google Scholar 

  30. Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B. von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology. 1995;194(3):629–42.

    Article  CAS  PubMed  Google Scholar 

  31. Fick GM, Johnson AM, Gabow PA. Is there evidence for anticipation in autosomal-dominant polycystic kidney disease? Kidney Int. 1994;45(4):1153–62.

    Article  CAS  PubMed  Google Scholar 

  32. Grampsas SA, Chandhoke PS, Fan J, Glass MA, Townsend R, Johnson AM, Gabow P. Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2000;36(1):53–7.

    Article  CAS  PubMed  Google Scholar 

  33. Kelleher CL, McFann KK, Johnson AM, Schrier RW. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population. Am J Hypertens. 2004;17(11 Pt 1):1029–34.

    Article  PubMed  Google Scholar 

  34. Gabow PA, Chapman AB, Johnson AM, Tangel DJ, Duley IT, Kaehny WD, Manco-Johnson M, Schrier RW. Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int. 1990;38(6):1177–80.

    Article  CAS  PubMed  Google Scholar 

  35. Bae KT, Zhu F, Chapman AB, Torres VE, Grantham JJ, Guay-Woodford LM, Baumgarten DA, King Jr BF, Wetzel LH, Kenney PJ, et al. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. Clin J Am Soc Nephrol. 2006;1(1):64–9.

    Article  PubMed  Google Scholar 

  36. Sherstha R, McKinley C, Russ P, Scherzinger A, Bronner T, Showalter R, Everson GT. Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. Hepatology. 1997;26(5):1282–6.

    CAS  PubMed  Google Scholar 

  37. Campbell GS, Bick HD, Varco RL, Paulsen EP, Lober PH, Watson CJ. Bleeding esophageal varices with polycystic liver: report of three cases. N Engl J Med. 1958;259(19):904–10.

    Article  CAS  PubMed  Google Scholar 

  38. Ryu SJ. Intracranial hemorrhage in patients with polycystic kidney disease. Stroke. 1990;21(2):291–4.

    Article  CAS  PubMed  Google Scholar 

  39. Wakabayashi T, Fujita S, Ohbora Y, Suyama T, Tamaki N, Matsumoto S. Polycystic kidney disease and intracranial aneurysms. Early angiographic diagnosis and early operation for the unruptured aneurysm. J Neurosurg. 1983;58(4):488–91.

    Article  CAS  PubMed  Google Scholar 

  40. Niemczyk M, Gradzik M, Niemczyk S, Bujko M, Golebiowski M, Paczek L. Intracranial aneurysms in autosomal dominant polycystic kidney disease. AJNR Am J Neuroradiol. 2013;34(8):1556–9.

    Article  CAS  PubMed  Google Scholar 

  41. Klein JP. On the role of screening for intracranial aneurysms in autosomal dominant polycystic kidney disease. AJNR Am J Neuroradiol. 2013;34(8):1560–1.

    Article  CAS  PubMed  Google Scholar 

  42. Huston 3rd J, Torres VE, Sulivan PP, Offord KP, Wiebers DO. Value of magnetic resonance angiography for the detection of intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1993;3(12):1871–7.

    PubMed  Google Scholar 

  43. Kato A, Takita T, Furuhashi M, Maruyama Y, Hishida A. Abdominal aortic aneurysms in hemodialysis patients with autosomal dominant polycystic kidney disease. Nephron. 2001;88(2):185–6.

    Article  CAS  PubMed  Google Scholar 

  44. Scheff RT, Zuckerman G, Harter H, Delmez J, Koehler R. Diverticular disease in patients with chronic renal failure due to polycystic kidney disease. Ann Intern Med. 1980;92(2 Pt 1):202–4.

    Article  CAS  PubMed  Google Scholar 

  45. Martinez JR, Grantham JJ. Polycystic kidney disease: etiology, pathogenesis, and treatment. Dis Mon. 1995;41(11):693–765.

    Article  CAS  PubMed  Google Scholar 

  46. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet. 1994;343(8901):824–7.

    Article  CAS  PubMed  Google Scholar 

  47. Nicolau C, Torra R, Badenas C, Vilana R, Bianchi L, Gilabert R, Darnell A, Bru C. Autosomal dominant polycystic kidney disease types 1 and 2: assessment of US sensitivity for diagnosis. Radiology. 1999;213(1):273–6.

    Article  CAS  PubMed  Google Scholar 

  48. Bae K, Park B, Sun H, Wang J, Tao C, Chapman AB, Torres VE, Grantham JJ, Mrug M, Bennett WM, et al. Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2013;8(7):1089–97.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Kistler AD, Serra AL, Siwy J, Poster D, Krauer F, Torres VE, Mrug M, Grantham JJ, Bae KT, Bost JE, et al. Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study. PLoS One. 2013;8(1):e53016.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  50. Higashihara E, Nutahara K, Okegawa T, Shishido T, Tanbo M, Kobayasi K, Nitadori T. Kidney volume and function in autosomal dominant polycystic kidney disease. Clin Exp Nephrol. 2013;18:157–65.

    Article  PubMed Central  PubMed  Google Scholar 

  51. Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King Jr BF, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, et al. Volume progression in polycystic kidney disease. N Engl J Med. 2006;354(20):2122–30.

    Article  CAS  PubMed  Google Scholar 

  52. Pirson Y, Chauveau D, Torres V. Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2002;13(1):269–76.

    PubMed  Google Scholar 

  53. Jouret F, Lhommel R, Devuyst O, Annet L, Pirson Y, Hassoun Z, Kanaan N. Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities. Nephrol Dial Transplant. 2012;27(10):3746–51.

    Article  CAS  PubMed  Google Scholar 

  54. Thong KM, Ong AC. The natural history of autosomal dominant polycystic kidney disease: 30-year experience from a single centre. QJM. 2013;106(7):639–46.

    Article  CAS  PubMed  Google Scholar 

  55. Hajj P, Ferlicot S, Massoud W, Awad A, Hammoudi Y, Charpentier B, Durrbach A, Droupy S, Benoit G. Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure. Urology. 2009;74(3):631–4.

    Article  PubMed  Google Scholar 

  56. Keith DS, Torres VE, King BF, Zincki H, Farrow GM. Renal cell carcinoma in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1994;4(9):1661–9.

    CAS  PubMed  Google Scholar 

  57. Torres VE, Chapman AB, Perrone RD, Bae KT, Abebe KZ, Bost JE, Miskulin DC, Steinman TI, Braun WE, Winklhofer FT, et al. Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney Int. 2012;81(6):577–85.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  58. Schrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, et al. Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med. 2014;371(24):2255–66.

    Article  PubMed Central  PubMed  Google Scholar 

  59. Lee YR, Lee KB. Ablation of symptomatic cysts using absolute ethanol in 11 patients with autosomal-dominant polycystic kidney disease. Korean J Radiol. 2003;4(4):239–42.

    Article  PubMed Central  PubMed  Google Scholar 

  60. Lee DI, Clayman RV. Hand-assisted laparoscopic nephrectomy in autosomal dominant polycystic kidney disease. J Endourol. 2004;18(4):379–82.

    Article  PubMed  Google Scholar 

  61. Eng M, Jones CM, Cannon RM, Marvin MR. Hand-assisted laparoscopic nephrectomy for polycystic kidney disease. JSLS. 2013;17(2):279–84.

    Article  PubMed Central  PubMed  Google Scholar 

  62. Mangoo-Karim R, Uchic M, Lechene C, Grantham JJ. Renal epithelial cyst formation and enlargement in vitro: dependence on cAMP. Proc Natl Acad Sci U S A. 1989;86(15):6007–11.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  63. Belibi FA, Wallace DP, Yamaguchi T, Christensen M, Reif G, Grantham JJ. The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2002;13(11):2723–9.

    Article  CAS  PubMed  Google Scholar 

  64. Gattone 2nd VH, Wang X, Harris PC, Torres VE. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med. 2003;9(10):1323–6.

    Article  CAS  PubMed  Google Scholar 

  65. Wang X, Gattone 2nd V, Harris PC, Torres VE. Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J Am Soc Nephrol. 2005;16(4):846–51.

    Article  CAS  PubMed  Google Scholar 

  66. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367(25):2407–18.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  67. Hogan MC, Masyuk TV, Page LJ, Kubly VJ, Bergstralh EJ, Li X, Kim B, King BF, Glockner J, Holmes 3rd DR, et al. Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol. 2010;21(6):1052–61.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  68. Walz G, Budde K, Mannaa M, Nurnberger J, Wanner C, Sommerer C, Kunzendorf U, Banas B, Horl WH, Obermuller N, et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2010;363(9):830–40.

    Article  CAS  PubMed  Google Scholar 

  69. Serra AL, Poster D, Kistler AD, Krauer F, Raina S, Young J, Rentsch KM, Spanaus KS, Senn O, Kristanto P, et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med. 2010;363(9):820–9.

    Article  CAS  PubMed  Google Scholar 

  70. He Q, Lin C, Ji S, Chen J. Efficacy and safety of mTOR inhibitor therapy in patients with early-stage autosomal dominant polycystic kidney disease: a meta-analysis of randomized controlled trials. Am J Med Sci. 2012;344(6):491–7.

    Article  PubMed  Google Scholar 

  71. Zerres K, Mucher G, Becker J, Steinkamm C, Rudnik-Schoneborn S, Heikkila P, Rapola J, Salonen R, Germino GG, Onuchic L, et al. Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology. Am J Med Genet. 1998;76(2):137–44.

    Article  CAS  PubMed  Google Scholar 

  72. Guay-Woodford LM, Desmond RA. Autosomal recessive polycystic kidney disease: the clinical experience in North America. Pediatrics. 2003;111(5 Pt 1):1072–80.

    Article  PubMed  Google Scholar 

  73. Roy S, Dillon MJ, Trompeter RS, Barratt TM. Autosomal recessive polycystic kidney disease: long-term outcome of neonatal survivors. Pediatr Nephrol. 1997;11(3):302–6.

    Article  CAS  PubMed  Google Scholar 

  74. Kaplan BS, Fay J, Shah V, Dillon MJ, Barratt TM. Autosomal recessive polycystic kidney disease. Pediatr Nephrol. 1989;3(1):43–9.

    Article  CAS  PubMed  Google Scholar 

  75. Hartung EA, Guay-Woodford LM. Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects. Pediatrics. 2014;134(3):e833–45.

    Article  PubMed Central  PubMed  Google Scholar 

  76. Onuchic LF, Furu L, Nagasawa Y, Hou X, Eggermann T, Ren Z, Bergmann C, Senderek J, Esquivel E, Zeltner R, et al. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am J Hum Genet. 2002;70(5):1305–17.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  77. Ward CJ, Hogan MC, Rossetti S, Walker D, Sneddon T, Wang X, Kubly V, Cunningham JM, Bacallao R, Ishibashi M, et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet. 2002;30(3):259–69.

    Article  PubMed  Google Scholar 

  78. Al-Bhalal L, Akhtar M. Molecular basis of autosomal recessive polycystic kidney disease (ARPKD). Adv Anat Pathol. 2008;15(1):54–8.

    Article  CAS  PubMed  Google Scholar 

  79. Bisceglia M, Galliani CA, Senger C, Stallone C, Sessa A. Renal cystic diseases: a review. Adv Anat Pathol. 2006;13(1):26–56.

    Article  PubMed  Google Scholar 

  80. Rajanna DK, Reddy A, Srinivas NS, Aneja A. Autosomal recessive polycystic kidney disease: antenatal diagnosis and histopathological correlation. J Clin Imaging Sci. 2013;3:13.

    Article  PubMed Central  PubMed  Google Scholar 

  81. Capisonda R, Phan V, Traubuci J, Daneman A, Balfe JW, Guay-Woodford LM. Autosomal recessive polycystic kidney disease: outcomes from a single-center experience. Pediatr Nephrol. 2003;18(2):119–26.

    PubMed  Google Scholar 

  82. Habib R, Bois E. Heterogeneity of early onset nephrotic syndromes in infants (nephrotic syndrome “in infants”). Anatomical, clinical and genetic study of 37 cases. Helv Paediatr Acta. 1973;28(2):91–107.

    CAS  PubMed  Google Scholar 

  83. Wen J. Congenital hepatic fibrosis in autosomal recessive polycystic kidney disease. Clin Transl Sci. 2011;4(6):460–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  84. Gunay-Aygun M, Font-Montgomery E, Lukose L, Tuchman Gerstein M, Piwnica-Worms K, Choyke P, Daryanani KT, Turkbey B, Fischer R, Bernardini I, et al. Characteristics of congenital hepatic fibrosis in a large cohort of patients with autosomal recessive polycystic kidney disease. Gastroenterology. 2013;144(1):112–21. e112.

    Article  PubMed Central  PubMed  Google Scholar 

  85. Telega G, Cronin D, Avner ED. New approaches to the autosomal recessive polycystic kidney disease patient with dual kidney-liver complications. Pediatr Transplant. 2013;17(4):328–35.

    Article  PubMed Central  PubMed  Google Scholar 

  86. Reuss A, Wladimiroff JW, Niermeyer MF. Sonographic, clinical and genetic aspects of prenatal diagnosis of cystic kidney disease. Ultrasound Med Biol. 1991;17(7):687–94.

    Article  CAS  PubMed  Google Scholar 

  87. Avni FE, Guissard G, Hall M, Janssen F, DeMaertelaer V, Rypens F. Hereditary polycystic kidney diseases in children: changing sonographic patterns through childhood. Pediatr Radiol. 2002;32(3):169–74.

    Article  PubMed  Google Scholar 

  88. Cobben JM, Breuning MH, Schoots C, ten Kate LP, Zerres K. Congenital hepatic fibrosis in autosomal-dominant polycystic kidney disease. Kidney Int. 1990;38(5):880–5.

    Article  CAS  PubMed  Google Scholar 

  89. Neumann HP, Krumme B, van Velthoven V, Orszagh M, Zerres K. Multiple intracranial aneurysms in a patient with autosomal recessive polycystic kidney disease. Nephrol Dial Transplant. 1999;14(4):936–9.

    Article  CAS  PubMed  Google Scholar 

  90. Chapal M, Debout A, Dufay A, Salomon R, Roussey G, Burtey S, Launay EA, Vigneau C, Blancho G, Loirat C, et al. Kidney and liver transplantation in patients with autosomal recessive polycystic kidney disease: a multicentric study. Nephrol Dial Transplant. 2012;27(5):2083–8.

    Article  PubMed  Google Scholar 

  91. Brinkert F, Lehnhardt A, Montoya C, Helmke K, Schaefer H, Fischer L, Nashan B, Bergmann C, Ganschow R, Kemper MJ. Combined liver-kidney transplantation for children with autosomal recessive polycystic kidney disease (ARPKD): indication and outcome. Transpl Int. 2013;26(6):640–50.

    Article  CAS  PubMed  Google Scholar 

  92. Bergmann C, Senderek J, Windelen E, Kupper F, Middeldorf I, Schneider F, Dornia C, Rudnik-Schoneborn S, Konrad M, Schmitt CP, et al. Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD). Kidney Int. 2005;67(3):829–48.

    Article  CAS  PubMed  Google Scholar 

  93. Adeva M, El-Youssef M, Rossetti S, Kamath PS, Kubly V, Consugar MB, Milliner DM, King BF, Torres VE, Harris PC. Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine. 2006;85(1):1–21.

    Article  PubMed  Google Scholar 

  94. Lilova M, Kaplan BS, Meyers KE. Recombinant human growth hormone therapy in autosomal recessive polycystic kidney disease. Pediatr Nephrol. 2003;18(1):57–61.

    Article  PubMed  Google Scholar 

  95. Fischer DC, Jacoby U, Pape L, Ward CJ, Kuwertz-Broeking E, Renken C, Nizze H, Querfeld U, Rudolph B, Mueller-Wiefel DE, et al. Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD). Nephrol Dial Transplant. 2009;24(6):1819–27.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urologic Surgery, Vanderbilt University Medical Center, A-1302 Medical Center North, Nashville, TN, 37232, USA

    Shreyas S. Joshi M.D. & Sam S. Chang M.D., M.B.A.

  2. Department of Pathology and Surgery, Section of Urology, University of Chicago Medical Center, Chicago, IL, 60637, USA

    Gladell P. Paner M.D.

Authors
  1. Shreyas S. Joshi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gladell P. Paner M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sam S. Chang M.D., M.B.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shreyas S. Joshi M.D. .

Editor information

Editors and Affiliations

  1. Department of Pathology, University of California at San Diego Department of Pathology, San Diego, California, USA

    Donna E. Hansel

  2. Department of Urology, University of California at San Diego Department of Urology, San Diego, California, USA

    Christopher J. Kane

  3. Department of Pathology and Surgery, University of Chicago, Chicago, Illinois, USA

    Gladell P. Paner

  4. Department of Urologic Surgery, Vanderbilt University Medical Center Department of Urologic Surgery, Nashville, Tennessee, USA

    Sam S. Chang

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Joshi, S.S., Paner, G.P., Chang, S.S. (2016). Polycystic Kidney Disease. In: Hansel, D., Kane, C., Paner, G., Chang, S. (eds) The Kidney. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3286-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3286-3_2

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3285-6

  • Online ISBN: 978-1-4939-3286-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation